NDC63323-0123-02 — METHOTREXATE SODIUM INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC63323-0123-02: METHOTREXATE SODIUM INJECTION.

The METHOTREXATE SODIUM INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAMUSCULAR AND INTRAVENOUS, special_features: CONTAINS PRESERVATIVE, primary_container_type: BOTTLE, protective_storage_feature: ANTINEOPLASTIC DRUG, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-020-2367, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC63323-0123-02

NSN: 6505-01-020-2367
FSC: 6505 — Drugs and Biologicals
CAGE: 1DQP2 — AMERICAN PHARMACEUTICAL PARTNERS (USA)

SPECIFICATIONS

administration	INTRAMUSCULAR AND INTRAVENOUS
special_features	CONTAINS PRESERVATIVE
primary_container_type	BOTTLE
protective_storage_feature	ANTINEOPLASTIC DRUG
pharmaceutical_vehicle_type	AQUEOUS
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	2.000 MILLILITERS
active_medicament_medicinal_strength	25.000 MILLIGRAMS METHOTREXATE PER MILLILITER
part_name_assigned_by_controlling_agency	METHOTREXATE SODIUM INJECTION USP 25MG/ML 2ML BT
NSN	6505-01-020-2367

COMPONENT DIAGRAM

KEY FEATURES

•

ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS

•

PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: BOTTLE

•

PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG

•

PHARMACEUTICAL VEHICLE TYPE: AQUEOUS

TECHNICAL CHARACTERISTICS

ADMINISTRATION	INTRAMUSCULAR AND INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY	2.000 MILLILITERS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	CONTAINS PRESERVATIVE
PROTECTIVE STORAGE FEATURE	ANTINEOPLASTIC DRUG
PART NAME ASSIGNED BY CONTROLLING AGENCY	METHOTREXATE SODIUM INJECTION USP 25MG/ML 2ML BT
PHARMACEUTICAL VEHICLE TYPE	AQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH	25.000 MILLIGRAMS METHOTREXATE PER MILLILITER

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES

No substitute or cross-reference records for this part.

LIFECYCLE

NSN statusActive· U.S. Government catalog

HAZMAT per U.S. Government catalogShelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC63323-0123-02?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC63323-0123-02?

NDC63323-0123-02 is a METHOTREXATE SODIUM INJECTION.

What is the NSN for NDC63323-0123-02?

NDC63323-0123-02 is cataloged in the U.S. Government catalog under NSN 6505-01-020-2367. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC63323-0123-02 — METHOTREXATE SODIUM INJECTION

Request a Quote — NDC63323-0123-02